Abstract
Abstract Machine learning is revolutionizing the analysis of biological and biomedical data. One continued challenge is to build models that are not only predictive but also provide mechanistic explanations. Directly incorporating explainability into the model’s design has emerged as a possible solution. Recently, we reported several “visible” machine learning systems - DCell and DrugCell - which predict cellular growth based on genetic perturbations. In these visible models, the structure of the underlying neural network mirrors known aspects of cell biology. Here we designed a cancer-specific model of therapeutic response. First, we selected NeST (Nested Systems in Tumors; Zheng et al., Science 2021), a data-driven hierarchy of tumor cell systems under selection in cancer, as the structure for our visible neural network. Second, we restricted input features to genes currently assayed on clinical cancer gene panels. We considered training schemes that assess the model’s ability to generalize to novel genotypes. Most importantly, we assessed performance on patient data from the AACR Project GENIE clinical trial where we discriminated between patients who are likely to respond to selected drug treatments. Finally, we examined model explanations within the visible NeST architecture to highlight cellular mechanisms of response to drug therapy. Overall, we found that by considering a tumor cell architecture optimized for clinical application, we can design an interpretable deep learning model that both accurately stratifies patient responses and explains the drug mechanism in cancer cells. Citation Format: Erica N. Silva, Akshat Singhal, Sungjoon Park, Jason Kreisberg, Trey Ideker. Prediction of therapeutic response via data-driven maps of tumor cell architecture [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 636.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.